367 related articles for article (PubMed ID: 34612136)
1. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of circ_0102273 inhibits the proliferation, metastasis and glycolysis of breast cancer through miR-1236-3p/PFKFB3 axis.
Yu H; Luo H; Liu X
Anticancer Drugs; 2022 Apr; 33(4):323-334. PubMed ID: 35266884
[TBL] [Abstract][Full Text] [Related]
3. TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis.
Zou L; Fang Y; He W
Mol Cell Probes; 2023 Jun; 69():101911. PubMed ID: 37003349
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma.
Li J; Zhang S; Liao D; Zhang Q; Chen C; Yang X; Jiang D; Pang J
BMC Cancer; 2022 Jan; 22(1):83. PubMed ID: 35057732
[TBL] [Abstract][Full Text] [Related]
5. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
[TBL] [Abstract][Full Text] [Related]
6. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3.
Doddaballapur A; Michalik KM; Manavski Y; Lucas T; Houtkooper RH; You X; Chen W; Zeiher AM; Potente M; Dimmeler S; Boon RA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):137-45. PubMed ID: 25359860
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
Wang L; Hou S; Li J; Tian T; Hu R; Yu N
Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
[TBL] [Abstract][Full Text] [Related]
8. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
9. Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation.
Boscaro C; Baggio C; Carotti M; Sandonà D; Trevisi L; Cignarella A; Bolego C
FASEB J; 2022 Mar; 36(3):e22140. PubMed ID: 35107852
[TBL] [Abstract][Full Text] [Related]
10. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
[TBL] [Abstract][Full Text] [Related]
11. MiR-34a-5p suppresses cutaneous squamous cell carcinoma progression by targeting SIRT6.
Chen S; Yuan M; Chen H; Wu T; Wu T; Zhang D; Miao X; Shi J
Arch Dermatol Res; 2024 May; 316(6):299. PubMed ID: 38819446
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.
Wang J; Li X; Xiao Z; Wang Y; Han Y; Li J; Zhu W; Leng Q; Wen Y; Wen X
FEBS Open Bio; 2019 Oct; 9(10):1798-1807. PubMed ID: 31410981
[TBL] [Abstract][Full Text] [Related]
13. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
15. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
[TBL] [Abstract][Full Text] [Related]
16. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
Deng X; Zhen P; Niu X; Dai Y; Wang Y; Zhou M
J Dermatol Sci; 2020 Oct; 100(1):67-74. PubMed ID: 32951990
[TBL] [Abstract][Full Text] [Related]
17. Role of PFKFB3 and CD163 in Oral Squamous Cell Carcinoma Angiogenesis.
Li JJ; Mao XH; Tian T; Wang WM; Su T; Jiang CH; Hu CY
Curr Med Sci; 2019 Jun; 39(3):410-414. PubMed ID: 31209811
[TBL] [Abstract][Full Text] [Related]
18. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
Lu D; Sun L; Li Z; Mu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
[TBL] [Abstract][Full Text] [Related]
19. PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer.
Dong C; Yao J; Wu Z; Hu J; Sun L; Wu Z; Yan J; Yin X
Sci Rep; 2024 Apr; 14(1):9196. PubMed ID: 38649699
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
